London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No need to ramp this one, all you need to know is in the link below. I will consolidate some of it anyway at some point for people who 'cba' to read through it all and I will note some of what I consider the most interesting points. Expecting them to start turning a profit in the next 6-12 months with all the ongoing contracts they have and government grants, all after the heavy investments that have been being made. Some key info: o Total income (revenue plus other income) up 40% to £2.0m o Cash of £1.95m at 31 March 2015 o IXICO has now been awarded contracts by nine of the top 15 global pharmaceutical companies http://www.investegate.co.uk/ixico-plc--ixi-/rns/replacement---financial-results/201502101625575629E/
Dated 30th June 2015 https://www.youtube.com/watch?v=I8Uuk9x9tz0
It really is the case that even modest demand has a quite positive effect on the sp. The amounts of stock showing as on offer from mm's on L2 is very small, so it really is the time to do your buying before the tempo rises. Looking back at the list of RNS's , IXI's certainly not short of positive newsflow.
Note - to maybe keep eyes pealed for some news here this week
Popped up today. Was this over looked? "VirtualScopics and IXICO Alliance Receive Awards in Oncology and Neurodegenerative Disease" http://www.prnewswire.com/news-releases/virtualscopics-and-ixico-alliance-receive-awards-in-oncology-and-neurodegenerative-disease-300105797.html With government financing secured, this seems like a fair punt IMO
So little stock on show....one that will always rise strongly on even modest demand.
I think you are right throth but where is the floor on this one? It seems to be in a death spiral. I have watched tis from around 38p and there is no sign of any bounce. It is in an interesting area and gets good grants but is unloved by the markets.
Great news re grant. I guess no private investors left. Due a re rating
Golddust, The forecasts come from IXI's broker Daniel Stewart. They are not computer-generated: they come from speaking to the company about its prospects. Obviously though they are just forecasts, and can be upgraded (or downgraded). But a forecast loss of £2M. for the current year puts me off, and I would be unlikely to buy unless it is upgraded.
I think you are way of the mark Hedgehog-these are only computer generated figures. Look at previous RNS's-all good news. Although last years results won't be brilliant (due to reorganisation costs after reverse takeover) the future from september 14 on looks very positive and I expect results will spark a rerating.
Here are the IXI forecasts from Digital Look: Forecast Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield 2014-09-30 3.40 -2.20 -14.20p 0.0 n/a 0% 0.00p 0.0% 2015-09-30 3.00 -2.00 -12.40p 0.0 n/a 0% 0.00p 0.0% http://www.digitallook.com/equity/Ixico And from Share.com: Forecasts Year Ending Profit (£m) EPS P/E PEG EPS Grth. Div Yield 30-Sep-15 (1.87) (12.40)p n/a n/a n/a n/a 0.0% https://www.share.com/find-investments/advanced-finder/company-overview/ixico/financials/forecasts/756/ The forecast for the results later this month is a loss of £2.2M. And then revenue is forecast to fall in the current year, with another massive loss. Suggestion of possible profit for the current year looks way off the mark, and with losses of about £2M. p.a. cash will not last too long unless something changes very dramatically.
As my previous post this latest RNS of contract valued £2.5 million on top of others announced this year seems to have been missed by the market which now makes IXICO an outstanding buy. Less its cash pile the company is only valued at about £2 million and will be in profit next year. Should be at least double on this news.
Ixico has dropped to a low for the year at 35p and in my view is due for a big bounce. The company is one of two on the market involved in Dementia diagnosis and has recently launched a dimentia diagnostic kit which it is promoting. With the immense focus on this disease by the government this could turn into really big business Directors were recently granted options at 49p with the ability to take these up subject to increasing the share price from 49p. The company has been doing very well lately too. An update is due from the company in December Cash in the bank of over £3 million and company valued at only £5.25 million inc cash this has got to be a steal.
Opps, just looked at the RNS's, looks like March time.
When is the AGM, that might force out some news here?
I bought in end last year on news of collaboration with Chinese re: dementure. A massive problem in China, as elsewhere. Paid 42p and within a few days was well over a pound. Top sliced 50% to get investment back plus some. Happy to hold the freeby shares, but it's going to be a looong wait. I'm sure it is doing all it can on research but will need a breakthrough on drugs, and if approved, no limit to how far sp can go. In MHO
I bought when Phytopharm so took a massive hit
My opinion is to avoid if you hold no shares in IXI and if you can sell without too big a loss do so and invest elsewhere. See testpack3 and my comments below...don't be fooled by large short term rises, the company do not have an income stream and need funding to do "something". When doing your research look at Phytopharm history too...they became Ixico.
Anyone think this is worth holding onto?
'What does it take to get the sp higher' - simple, an income stream from products which will provide +ve EBITDA.
A few thousand sells and the Mms would drop this share , and all week there have been mostly buys and the share price doesn't move at all...so what is going on...mm's playing silly games? This should be at the 80p level by now and heading to multiply many times over....just like GW pharma, and skyepharma...What does it to take to get the sp higher...a midas tip, perhaps? Strong buy
I could not agree more with you son. These boards are full of fools, rampers, knaves and faceless jokers. You have my sympathy but maybe education is never free.
66%...very good point! This share was Phytopharm (PYM) and is following a similar pattern...share price goes up, investors pay high price, then down it drops. My PYM, now IXI, shares have lost 94% in 3 yrs and never been above what I paid for them. IXI shares will do the same unless they really develop a product of value otherwise you're just funding the directors...there are far better safer investments on FTSE100!! Just be wary, DYOR and good luck if you believe IXI is worth the investment.